| Heather Foresman, APRN,CNM | |
|
705 Pleasant Ave S, Park Rapids, MN 56470-1440 | |
| (218) 732-2800 | |
| Not Available |
| Full Name | Heather Foresman |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 705 Pleasant Ave S, Park Rapids, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396299079 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | B119198 (Iowa) | Primary |
| Entity Name | Lake Region Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093713372 PECOS PAC ID: 3971565334 Enrollment ID: O20060109000246 |
News Archive
Coinciding with the annual European Respiratory Society Congress, ERS 2012, SPIRIVA (tiotropium), the first once-daily long-acting inhaled anticholinergic maintenance treatment for patients with Chronic Obstructive Pulmonary Disease (COPD) will mark its 10th anniversary since launch.
A new report shows that Britain's NHS pays out £60,000 a day on translation and interpretation services, with Leeds among the highest spenders. Research by think-tank 2020Health showed NHS trusts spent £23.3 million on written translation and interpreters last year, an increase of 17% since 2007.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Foresman, APRN,CNM Po Box 6001, Fargo, ND 58108-6001 Ph: (701) 364-8000 | Heather Foresman, APRN,CNM 705 Pleasant Ave S, Park Rapids, MN 56470-1440 Ph: (218) 732-2800 |
News Archive
Coinciding with the annual European Respiratory Society Congress, ERS 2012, SPIRIVA (tiotropium), the first once-daily long-acting inhaled anticholinergic maintenance treatment for patients with Chronic Obstructive Pulmonary Disease (COPD) will mark its 10th anniversary since launch.
A new report shows that Britain's NHS pays out £60,000 a day on translation and interpretation services, with Leeds among the highest spenders. Research by think-tank 2020Health showed NHS trusts spent £23.3 million on written translation and interpreters last year, an increase of 17% since 2007.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, pain control and critical care, today announced that it has granted the Japanese development and commercialization rights to its oncology therapy Erwinase(R) to Ohara Pharmaceutical Company Limited. The agreement represents the first product partnership EUSA has established in Japan.
AbbVie today announced that it has entered into an exclusive worldwide license agreement with C2N Diagnostics, a privately held protein diagnostic and therapeutic discovery company, to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease and other neurological disorders.
› Verified 6 days ago